SCHEMBL8095485

SCHEMBL8095485

N#Cc1cc(-c2ccc(S(N)(=O)=O)cc2)c(-c2ccc(F)cc2)nc1SCc1ccoc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.44
PTGS2 P35354 10/20 0.43
CA12 O43570 3/20 0.40
CA1 P00915 3/20 0.40
CA2 P00918 3/20 0.40
CA9 Q16790 3/20 0.40
PTGS1 P23219 5/20 0.39
CNR1 P21554 1/20 0.39
CNR2 P34972 1/20 0.39
MAPK13 O15264 1/20 0.39
MAPK12 P53778 1/20 0.39
MAPK11 Q15759 1/20 0.39
MAPK14 Q16539 1/20 0.39
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
CDK1 P06493 1/20 0.37
KDR P35968 1/20 0.37
IKBKB O14920 1/20 0.36
CHUK O15111 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8094384 0.90 MAPK13 (0.47) ALDH1A1LMNAPTGS2CA12CA1
SCHEMBL8095193 0.83 CNR1 (0.46) ALDH1A1LMNAPTGS2CA12CA1
SCHEMBL8086039 0.83 TSHR (0.50) ALDH1A1LMNAPTGS2CA12CA1
SCHEMBL8086490 0.82 ALDH1A1 (0.42) ALDH1A1LMNAPTGS2CA12CA1
SCHEMBL8093245 0.80 ALDH1A1 (0.45) ALDH1A1LMNAPTGS2CA12CA1
SCHEMBL8092804 0.80 MAPK13 (0.59) ALDH1A1LMNAPTGS2PTGS1CNR1
SCHEMBL8095741 0.79 PDE10A (0.43) ALDH1A1LMNAPTGS2CA12CA1
SCHEMBL8104361 0.79 ALDH1A1 (0.46) ALDH1A1LMNAPTGS2CA12CA1
SCHEMBL8093490 0.78 ALDH1A1 (0.51) ALDH1A1LMNACA12CA1CA2
SCHEMBL8421622 0.78 ALDH1A1 (0.40) ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0808304-B1 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2000-12-27 EP disclosed